ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977

In Brief: NCI Terminates Straus’ Grant Following Site Visit Report Charging “Lack Of satisfactory Progress

February 19, 1982

In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference

August 16, 1991

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

In Brief: House Passes appropriations Bill; Senate Markup in Late Summer; Kirschstein Acting NIH Director

July 9, 1993